Gastroenterology

A patient, 62 years of age, with type 2 diabetes, obesity, and an intellectual disability disorder, had been a patient at our clinic for over ten years. Treatment included metformin and insulin. He met regularly with his endocrinologist and diabetes educator. He often spoke about wanting to lose weight....

Three recent studies reveal insights into potential links between the gut microbiome and type 2 diabetes mellitus (T2DM).  

The intestinal microbiota in people with type 1 and those with MODY2 differs in abundance and type compared to people without.

A new study finds that proteins found in the gut can distinguish patients with type 1 diabetes and islet autoimmunity from healthy individuals.

This is not one patient’s disaster averted but what I have experienced working in the field of diabetes and obesity for years. Many times patients who are taking glucose lowering and/or anti obesity medications will report different GI complaints-such as bloating, diarrhea, constipation, nausea, vomiting, and GERD. They tell me they are going to see a gastroenterologist for an evaluation.

Study finds fewer T2 patients on exenatide once-weekly reported gastrointestinal adverse events, compared with those on exenatide twice-daily or liraglutide once-daily.

Initiation of glucagon like peptide-1 agonists may increase risk of gallbladder or bile duct disease and cholecystectomy; no increased risk associated with DPP-4 inhibitor therapy.

Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 1 Chapter 22 Gastroparesis Anumber of times throughout this book, you’ve come across the terms “delayed stomach-emptying” and “gastroparesis.” As I explained in Chapter 2, elevated blood sugars for prolonged periods can impair the ability of nerves to function properly.  …

Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 2 Chapter 22 Gastroparesis How Does Gastroparesis Affect Blood Sugar Control? – Part 2Consider the individual who has very little phase I insulin release and must take fast-acting insulin or one of the older-type (sulfonylurea) or newer pancreas-provoking OHAs before …

Diabetes Solution Richard K. Bernstein, MD, FACE, FACN, FACCWS Part 3 Chapter 22 Gastroparesis Efforts at diagnosis are usually unnecessary if there is no reason to suspect the presence of gastroparesis. So first we must have an index of suspicion. If, at the initial history-taking interview with your physician, you …